Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001583665 | SCV001819944 | uncertain significance | not provided | 2024-10-23 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV001583665 | SCV002358019 | likely benign | not provided | 2024-11-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002573321 | SCV003720565 | uncertain significance | Inborn genetic diseases | 2021-09-29 | criteria provided, single submitter | clinical testing | The c.11374C>T (p.R3792W) alteration is located in exon 9 (coding exon 9) of the FAT4 gene. This alteration results from a C to T substitution at nucleotide position 11374, causing the arginine (R) at amino acid position 3792 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV003434312 | SCV004116777 | uncertain significance | FAT4-related disorder | 2023-03-09 | criteria provided, single submitter | clinical testing | The FAT4 c.11380C>T variant is predicted to result in the amino acid substitution p.Arg3794Trp. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.051% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/4-126373545-C-T). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
ARUP Laboratories, |
RCV001583665 | SCV004564954 | uncertain significance | not provided | 2023-11-22 | criteria provided, single submitter | clinical testing |